US regulators have approved a first-of-its-kind implant that can help ward off moderate to severe sleep apnea, a chronic disorder which affects up to 18 million Americans. Sleep apnea is a condition in which the breathing passage collapses or becomes blocked during sleep — complications can include heart disease and increased risks of accidents and death. The Inspire Upper Airway Stimulation therapy, which has been given the green light by the US Food and Drug Administration, is designed for patients unable to benefit from available therapies.
from Yahoo Tech http://ift.tt/1i0Uas0
via
from Yahoo Tech http://ift.tt/1i0Uas0
via
Blogger Comment